根據美國生技產業協會（Biotechnology Industry Organization, BIO）的資料顯示，純研發型的生技公司難以取得投資資金，且投資者對公司的現金部位益發看重。而我國的台灣經濟研究院調查也指出國內生技廠商在研發階段所面臨到的重大困難是「資金取得不易」，這些正反應出國內外投資者對生技產業特殊性的疑慮，進而不願意投入大量資金。 為解決國內生技研發型公司資金不足之問題，本論文分析了美國生技公司籌資狀況及常使用之工具，並考量台灣生技產業所面臨之整體環境，為國內生技企業建立了具實用價值的特殊籌資工具及發行模式，以滿足不同的籌資需求及降低投資者的風險。而為驗證此一籌資工具之可行性，本論文也挑選國內一家生技研發型公司，以其業務及財務現況，進行特殊籌資工具之定價，並提供發行前後應注意之相關事項。 / According to the research report from BIO（Biotechnology Industry Organization）, it is hard for research-based biotech companies to get financing and investors are more concerned about whether the company has enough cash or not .The same result can be found in the investigation of Taiwan Institute of Economic Research（TIER）.They find out the research-based biotech companies in Taiwan encounter one difficult problem - hard to get enough money to support their R&D .All these facts just reflect the special characteristics of biotech industry and the investment trend among biotech field. The goal of this thesis is to resolve the financing problem faced by the research-based biotech companies in Taiwan, so we analyze how American biotech companies get enough financing to support their R&D, and then, construct the special financing tool for the research-based biotech companies under the economical situation in Taiwan, in order to fulfill the needs of biotech companies and reduce the investment risk. In this thesis, we use a case study to verify the pricing model of special financing tool and propose some material facts should be resolved when stocks issuing.

本文主要目的擬以台灣某上市司所發行海外可轉換交換債為例，探討海外可轉換交換債作為我國上市公司財務工具的可行性、作業、管理及其成本效益。海外可轉換交換債，是現代財務衍生的一項籌資工具，在台灣尚不算極普及的財務工具應用。國際企業身處在一個整合和變動的世界經濟活動中，如何利用台灣上市公司的企業利基，運用海外可轉換交換債取得國際資金和資金成本效益。本研究選擇以探討海外可轉換交換債作為我國上市公司財務工具的可行性，並且深入了解其必需具備的各項企業條件及選擇可轉換標的決策考量，探討發行海外可轉換交換債的各項法規限制及發行海外可轉換交換債的國際金融環境，以研究發行海外可轉換交換債的應用及其成本效益，了解組織財務管理及發行海外可轉換交換債的各項作業與決策管理，並透過海外可轉換交換債與其它財務工具的成本效益比較海外可轉換交換債此項財務工具的實質效益。 / The main purpose of this thesis is to discuss the possibilities, operation, management and cost-effectiveness of European Exchangeable Bonds by using a Taiwanese listed company as an example. European Exchangeable Bonds is a modern financing tool that it’s still not a popular application in Taiwan. However, international corporations are in integrated and dynamic world economic activities. We’d like to discuss how to use the advantages of the Taiwanese listed company to make use of European Exchangeable Bonds to get international funds and make profit on cost of capital. The research would choose a company as instance to discuss in deep about the feasibility of European Exchangeable Bonds and the considerations of issuing European Exchangeable Bonds. We will research the restrictions of issuing process and the international financing environment and to discover the application and operation cost effectiveness of European Exchangeable Bonds, and then compare practical benefits between European Exchangeable Bonds and other financing tools.